Get Help 24/7

Search
CA -19.9 (Pancreatic Cancer Marker) Test

Report Delivery Time: Next Day

Recommended Gender: Both

Sample Type: Blood

The CA 19-9 (Pancreatic Cancer Marker) Test measures the levels of carbohydrate antigen 19-9 (CA 19-9) in the blood. It is primarily used to monitor pancreatic cancer, assess treatment effectiveness, and detect other cancers or gastrointestinal conditions.

1,200.00

Whatsapp

+919354028488

Email Address

info@hprimelabs.com

Email Address

customercare@hprimelabs.com

1,200.00

Whatsapp

+919354028488

Email Address

info@hprimelabs.com

Related Packages

Related Tets

The CA 19-9 test measures levels of the tumor marker carbohydrate antigen 19-9, which is often elevated in pancreatic cancer and some biliary tract cancers. While not a standalone diagnostic tool, it plays a powerful role in monitoring cancer progression, treatment response, and recurrence. It may also rise in non-cancerous conditions like pancreatitis or liver disease, making it a valuable indicator of pancreatic and biliary health.

Why is the CA 19-9 Test Done?

Doctors commonly use this test to:

  • Monitor pancreatic cancer progression and detect recurrence

  • Evaluate treatment effectiveness, including chemotherapy or surgery

  • Assess bile duct and gallbladder cancers

  • Differentiate pancreatic disorders from other conditions

Who Should Get CA 19-9 Test?

This test is helpful for individuals who:

  • Already have pancreatic cancer and need ongoing monitoring

  • Experience symptoms like unexplained weight loss, jaundice, abdominal pain, or loss of appetite

  • Are at high risk due to family history

  • Need follow-up after cancer treatment

Test Procedure & Preparation

  • Preparation:

    • No fasting required

    • Avoid biotin supplements for 48 hours

    • Inform your doctor of any liver or pancreatic issues

  • Procedure:

    • Blood sample taken from a vein

    • Analyzed using ELISA or CLIA

    • Results in 1–3 days

Understanding the Results

  • Normal: Less than 37 U/mL

  • Higher levels may indicate:

    • Pancreatic cancer

    • Bile duct or gallbladder cancer

    • Colorectal cancer

    • Pancreatitis or liver disease

  • Mild increases can occur due to gallstones, inflammation, or benign digestive conditions

Note: Some individuals (Lewis-negative blood type) do not produce CA 19-9 even if cancer is present.

Limitations

  • Not reliable for early cancer detection

  • Can give false positives in non-cancer conditions

  • Must be combined with imaging or biopsy for accurate diagnosis

Why This Test Matters

The CA 19-9 test is a powerful tool in managing pancreatic and biliary cancers, helping doctors track disease changes, evaluate treatment success, and detect recurrence early — ultimately supporting better treatment decisions and patient outcomes.

Book your Health Checkup today

Browse Hprime Resources

Other links

  1. blogspot.com
  2. Linktree
  3. Pinterest
Scroll to Top